Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Fenirofibrate impurity 5 is a drug impurity associated with Fenirofibrate, a fibrate-class medication primarily used to manage dyslipidemia. This impurity may serve as a critical reference standard for analytical and quality control in pharmaceutical research, particularly in the assessment of purity and safety profiles of Fenirofibrate formulations. Its identification and characterization contribute to the overall understanding of Fenirofibrate’s pharmacological properties and regulatory compliance. -
Drug Impurity
Fesoterodine impurity 1 is a known impurity of the antimuscarinic agent Fesoterodine, which primarily targets muscarinic acetylcholine receptors. This compound is important for quality control and characterization in the synthesis and analysis of Fesoterodine and its derivatives. It serves as a reference standard in research applications related to drug purity assessments and pharmacological studies. -
Drug Impurity
Olanzapine impurity 3 is a chemical impurity associated with the antipsychotic drug Olanzapine. This compound is primarily utilized in pharmaceutical research for quality control and validation processes, ensuring the integrity and safety of Olanzapine formulations. Its identification and quantification assist in understanding the pharmacological profile and potential effects of the drug, contributing to the overall assessment of drug safety and efficacy. -
Drug Impurity
Levetiracetam Impurity B is a chemical impurity associated with Levetiracetam, a medication primarily used in the management of epilepsy. This compound serves as a reference standard for quality control and analytical testing in pharmaceutical research. It is critical for evaluating the purity and consistency of Levetiracetam formulations in developmental studies and regulatory submissions. -
Drug Impurity
Everolimus impurity 9 is a chemical impurity associated with the immunosuppressant drug Everolimus. This impurity can be utilized for quality control and analytical purposes in pharmaceutical research to ensure the purity and efficacy of drug formulations. Its presence in samples may influence the overall pharmacological profile, making it an important consideration in drug development and safety assessments. -
Drug Impurity
Cannabigerobutol (CBGB) is identified as an impurity related to the cannabinoid cannabigerol. Due to its structural similarities, it may exhibit biological activities that contribute to the pharmacological profile of cannabinoid products. Research applications include the study of cannabinoid metabolism and the effects of impurities on the efficacy and safety of cannabinoid-based therapies. -
Drug Impurity
Telmisartan impurity 14 is a chemical impurity associated with the antihypertensive drug Telmisartan. As a drug impurity, it is important for method validation and quality control in pharmaceutical development. This compound is essential for ensuring adherence to regulatory standards and assessing the purity of Telmisartan formulations. Utilization of Telmisartan impurity 14 is critical in research applications focused on drug safety and efficacy. -
Drug Impurity
Fenirofibrate impurity 6, also known as Fenirofibrate impurity D, is a drug impurity associated with the pharmaceutical compound Fenirofibrate. This impurity may be relevant for qualitative analysis and stability testing within pharmaceutical formulations. Researchers can utilize this compound to better understand the purity and safety profiles of Fenirofibrate during drug development processes. -
Drug Impurity
Aripiprazole impurity 33 is a chemical impurity associated with the antipsychotic drug Aripiprazole. This compound is relevant for pharmaceutical research and quality control, particularly in the assessment of drug purity and safety profiles. Its identification and quantification can aid in the development and validation of analytical methods for ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Albendazole impurity 10 is a synthetic impurity associated with the anthelmintic compound Albendazole. It serves as a critical reference standard for analytical and quality control applications, enabling the identification and quantification of impurities in pharmacological formulations. This reagent is essential for ensuring the purity and efficacy of Albendazole in various research and clinical settings. -
Drug Impurity
Rosuvastatin impurity 28 is a identified impurity of Rosuvastatin, a potent HMG-CoA reductase inhibitor. This compound is essential for assessing the purity and quality of Rosuvastatin in pharmaceutical formulations. Its analysis is crucial for regulatory compliance and research applications related to drug development and quality control in the pharmaceutical industry. -
Drug Impurity
Febuxostat impurity 50 is a characterized impurity of Febuxostat, a selective xanthine oxidase inhibitor. This compound is crucial for analytical chemists in the assessment of drug purity and stability. It serves as a standard reference for quality control and method development in pharmaceutical research involving hypoxanthine and purine metabolism. -
Drug Impurity
Dabigatran impurity 52 is a drug impurity associated with Dabigatran, a direct thrombin inhibitor. This compound is primarily utilized for quality control and analytical studies in pharmaceutical research. Its characterization is essential for ensuring the safety and efficacy of therapeutic formulations containing Dabigatran. -
Drug Impurity
Ciprofloxacin impurity 9, also known as Formyl Ciprofloxacin, is a recognized impurity of the antibiotic ciprofloxacin. Its characterization is crucial for quality control and regulatory compliance in pharmaceutical development. This compound is used in research applications focusing on the assessment of drug purity, stability studies, and the investigation of potential metabolites in ciprofloxacin synthesis. -
Drug Impurity
Olmesartan impurity 12 is a chemical impurity associated with the antihypertensive agent Olmesartan, which primarily targets the angiotensin II receptor. This impurity is vital for analytical research in pharmacokinetics and can be utilized in the assessment of the purity of Olmesartan formulations. Its identification and quantification are essential for regulatory compliance and quality control in pharmaceutical development. -
Drug Impurity
Hydroxychloroquine impurity 2 is a chemical impurity associated with Hydroxychloroquine, an antimalarial and autoimmune disease therapeutic agent. This reagent is essential for analytical studies and quality control in pharmaceutical research, facilitating the evaluation of drug purity and safety. Its characterization plays a crucial role in the development and compliance of medicinal formulations containing Hydroxychloroquine. -
Drug Impurity
Dasatinib impurity 4, also known as Deschloro Dasatinib, is a known impurity associated with the anticancer drug Dasatinib. It serves as a valuable reference standard for analytical studies and quality control in pharmaceutical research. This compound is essential for evaluating the purity and safety of Dasatinib formulations, contributing to the development of effective cancer therapies. -
Drug Impurity
Bumetanide impurity 3 is a known impurity associated with the loop diuretic compound Bumetanide. This compound is primarily used in the evaluation of drug purity and quality control in pharmaceutical formulations. Its characterization is essential for adhering to regulatory standards and ensuring the efficacy and safety of Bumetanide-based therapies. -
Drug Impurity
Apixaban impurity 22 is a characterized impurity associated with the anticoagulant drug Apixaban. Its presence can be critical for quality control in pharmaceutical formulations and analytical research. This reagent is utilized in the study of drug synthesis processes and stability, ensuring the purity and safety of Apixaban in various applications. -
Impurity reference
ent-Abacavir serves as an impurity reference in chemical research. It is an enantiomer of Abacavir, which functions as a competitive nucleoside reverse transcriptase inhibitor. This compound is crucial for studies focusing on the pharmacology and quality control of antiretroviral therapies, specifically in elucidating the effects of chiral centers in drug metabolism and efficacy. -
Drug Impurity
Edoxaban impurity 5 is a chemical impurity associated with the anticoagulant Edoxaban. This impurity is crucial for analytical and quality control applications in pharmaceutical research, particularly in assessing the purity and stability of Edoxaban formulations. Its characterization aids in understanding the compound's behavior and potential impacts on drug efficacy and safety. -
Drug Impurity
Rufinamide impurity 2 is a known impurity associated with the antiepileptic drug Rufinamide. This compound is important for analytical chemistry applications, particularly in the characterization and quality control of pharmaceutical products containing Rufinamide. The study of its properties and behavior may aid in understanding the overall stability and safety profiles of the drug formulation. -
Drug Impurity
Aripiprazole impurity 10 is a recognized impurity of the antipsychotic agent aripiprazole. It is relevant in the context of drug stability and quality control in pharmaceutical development. This compound is used for analytical purposes in the characterization and quantification of aripiprazole formulations, ensuring the integrity and safety of the active pharmaceutical ingredient. -
Drug Impurity
Haloperidol Impurity 9 is a known impurity of the antipsychotic agent Haloperidol. Its characterization is essential for quality control and regulatory compliance in pharmaceutical research. The identification and quantification of this impurity can aid in understanding the safety and efficacy profiles of Haloperidol, making it crucial for drug development and formulation studies. -
Drug Impurity
Roxithromycin impurity 1 is a characterized impurity associated with Roxithromycin, an azalide antibiotic. It serves as a reference standard for analytical purposes, particularly in the assessment of drug purity and stability. This impurity is essential for quality control and regulatory compliance in pharmaceutical development, contributing to the comprehensive understanding of Roxithromycin's chemical profile. -
Drug Impurity
Terbinafine impurity 8 is a drug impurity associated with terbinafine, an antifungal agent. This compound is utilized in the analysis and quality control of terbinafine formulations, enabling researchers to assess the purity and authenticity of pharmaceutical products. Its characterization is essential for regulatory compliance and the development of stable drug formulations. -
Drug Impurity
Losartan impurity 16, also known as Losartan impurity C, is a known impurity associated with the synthesis of the antihypertensive drug Losartan. This compound serves as an important reference material for quality control in pharmaceutical formulations and ensures the purity and safety of drug products. Its characterization supports compliance with regulatory standards during drug development and manufacturing processes. Researchers can utilize this impurity to understand its impact on the overall quality of Losartan preparations. -
Losartan Impurity
Losartan impurity 14 is a chemical variant of Losartan featuring an azido group in its structure. This compound serves as an important intermediate in synthetic chemistry, allowing for the conversion to an amino compound through the use of organophosphorus reagents. Its application is crucial for research focused on drug synthesis and quality control in the development of Losartan-related pharmaceuticals. -
Drug Impurity
Progesterone impurity 5 is a chemical impurity related to progesterone, primarily identified in the synthesis and quality control of progesterone formulations. This impurity may influence the pharmacological profile and efficacy of progesterone-based therapeutic agents. It is utilized in research applications focused on drug development, formulation stability, and regulatory compliance for hormonal medications. -
Drug Impurity
Rivaroxaban Impurity 8 is an impurity variant associated with the anticoagulant Rivaroxaban. This compound is essential for quality control and analytical assessment in pharmaceutical development. Its characterization aids in understanding the stability and integrity of Rivaroxaban formulations, making it a valuable reference standard in drug impurity research and regulatory compliance. -
Drug Impurity
Palbociclib N-aldehyde is an impurity related to the CDK4/6 inhibitor Palbociclib, functioning primarily by inhibiting cell cycle progression in cancer cells. This compound is crucial for analytical and quality control applications in pharmaceutical research, particularly in studies focused on the purity assessment of Palbociclib formulations. Its presence can provide insights into synthetic pathways and stability, contributing to the overall understanding of drug formulation and efficacy. -
Drug Impurity
Doxycycline impurity 1 is a known impurity associated with the antibiotic doxycycline. It serves as a valuable reference standard for assessing the quality and purity of doxycycline formulations during pharmaceutical development and quality control processes. This reagent is essential for analytical studies aiming to identify and quantify impurities to ensure compliance with regulatory standards. -
Drug Impurity
Rufinamide impurity 4 is a specified impurity associated with Rufinamide, a drug used in the treatment of epilepsy. This compound is primarily utilized for quality control and research applications to assess the purity of pharmaceutical formulations. Its identification and characterization are crucial for ensuring the safety and efficacy of Rufinamide-based therapies. -
Drug Impurity
Pemetrexed impurity 25 is a drug impurity associated with Pemetrexed, a multi-targeted antifolate used primarily in cancer therapy. This compound is relevant for identifying and characterizing impurities in pharmaceutical formulations, ensuring quality control during drug development. Its analysis supports compliance with regulatory standards in the assessment of pharmaceutical integrity and safety. -
Drug Impurity
Edoxaban impurity 13 lithium is a chemical impurity associated with Edoxaban lithium. This impurity is relevant for analytical and quality control studies, as it helps in the assessment of drug purity and the safety profile of pharmaceutical formulations. Its identification and quantification are crucial for ensuring compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Cetirizine impurity 1 is a characterized impurity of Cetirizine, an antihistamine used to treat allergic reactions. This compound is important for quality control in pharmaceutical formulations of Cetirizine, ensuring the safety and efficacy of the final product. It provides essential insight into the synthetic pathways and purification processes involved in drug production. Researchers can utilize Cetirizine impurity 1 for method development and validation in analytical chemistry studies. -
Drug Impurity
Hydroxychloroquine impurity 4 is a known impurity of hydroxychloroquine, primarily identified during the synthesis and quality control of this anti-malarial and anti-inflammatory compound. Research applications include the assessment of drug purity and stability, as well as studies investigating the pharmacological effects and safety profiles of hydroxychloroquine. This impurity serves as a critical reference for analytical methods and regulatory compliance in pharmaceutical development. -
Drug Impurity
Amodiaquine impurity 2, also known as N-Desethyl amodiaquine hydrochloride, serves as a drug impurity of Amodiaquine. This compound is utilized primarily in quality control and analytical chemistry, particularly for assessing the purity of pharmaceutical formulations containing Amodiaquine. Its characterization is essential for ensuring the safety and efficacy of therapeutic agents during drug development and manufacturing processes. -
Drug Impurity
Edoxaban impurity 20 is a minor impurity associated with the anticoagulant Edoxaban. This compound plays a crucial role in pharmaceutical research, particularly in the analysis and characterization of drug formulations. Its presence is essential for assessing the purity and quality of Edoxaban, ensuring compliance with regulatory standards in drug development and production. -
Drug Impurity
Cetirizine impurity 10, also known as Cetirizine amide, is a specific impurity associated with the antihistamine cetirizine. It is primarily utilized for analytical and quality control purposes in pharmaceutical research, facilitating the assessment of drug purity and stability. This compound serves as a critical standard in identifying and quantifying impurities during the development and manufacturing processes. -
Drug Impurity
Paracetamol impurity 3, also known as p-Chloroacetanilide, is a known impurity associated with the synthesis of Paracetamol. This compound is frequently analyzed in pharmacological studies and quality control assessments to ensure the purity of Paracetamol formulations. Its detection and characterization are crucial for regulatory compliance and the evaluation of pharmaceutical quality. -
Drug Impurity
Salbutamol impurity 3, also known as Salbutamol impurity K, is classified as a drug impurity associated with Salbutamol. This compound is primarily utilized in analytical chemistry for the characterization and quantification of Salbutamol formulations. Its identification is crucial for ensuring the quality and safety of pharmaceutical products containing Salbutamol. -
Drug Impurity
Lamivudine impurity 7 is a characterized impurity of the antiviral agent Lamivudine. This compound is critical for quality control and pharmacological assessments in the development of Lamivudine-based therapies. Its analysis is important for ensuring the purity and safety of pharmaceutical formulations containing Lamivudine, and it serves as an analytical standard in regulatory submissions and research applications. -
Drug Impurity
Azilsartan impurity 21, also known as Desethyl azilsartan medoxomil, is a notable impurity associated with Azilsartan. It serves as a critical reference standard in the analysis of pharmaceutical formulations, particularly for quality control and method validation. This compound can be utilized in research focused on the pharmacokinetics and metabolism of Azilsartan, aiding in the assessment of drug purity and stability in various formulations. -
Drug Impurity
Clindamycin palmitate impurity 5, also known as Clindamycin pentadecanoate, is identified as a drug impurity associated with clindamycin formulations. Its presence may influence the pharmacokinetic profiles and safety assessments of clindamycin-based therapies. This compound is crucial for researchers engaged in drug stability studies, impurity profiling, and formulation development within pharmaceutical and medicinal chemistry contexts. -
Drug Impurity
Clindamycin palmitate impurity 8, also known as Clindamycin 3-palmitate, is a drug impurity associated with the antibiotic clindamycin. This compound serves as a significant analytical reference for quality control and research applications in pharmaceutical development. Its presence may impact the efficacy and safety profiles of clindamycin formulations, making it essential for comprehensive studies on drug composition and stability. -
Drug Impurity
Betamethasone acetate impurity 2 is an impurity associated with Betamethasone acetate, a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties. This compound is utilized primarily in analytical chemistry to assess the purity of Betamethasone acetate formulations. Research applications include quality control and characterization of pharmaceutical products, ensuring compliance with regulatory standards. -
Drug Impurity
Palbociclib impurity 49 is a chemical impurity associated with the drug palbociclib, a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). This impurity serves as a key standard for analytical applications in drug development and quality control processes. Its characterization is essential for ensuring the purity and efficacy of palbociclib formulations in preclinical and clinical research. -
Drug Impurity
Citalopram impurity 2, also known as (rac)-Didemethyl citalopram, serves as a known impurity in the synthesis of Citalopram. This chemical compound is relevant for analytical chemists seeking to assess the purity of pharmaceutical preparations and to understand potential degradation products. Its characterization is crucial for quality control in the development of selective serotonin reuptake inhibitors (SSRIs). -
Drug Impurity
Rivaroxaban impurity 21 is a chemical impurity associated with Rivaroxaban, a direct factor Xa inhibitor. This compound can be utilized for analytical purposes in the quality control of pharmaceutical formulations and in research to understand the synthesis and degradation pathways of Rivaroxaban. Its identification and quantification are essential for ensuring the purity and safety of Rivaroxaban-based products.
